According to Allakos's latest financial reports the company has a price-to-book ratio of 1.07.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | N/A | -100% |
2023-12-31 | 1.41 | -38.79% |
2022-12-31 | 2.31 | 93.61% |
2021-12-31 | 1.19 | -89.37% |
2020-12-31 | 11.2 | 19.98% |
2019-12-31 | 9.36 | -21.75% |
2018-12-31 | 12.0 | |
2017-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | 0.7844 | -26.89% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | 3.48 | 223.92% | ๐บ๐ธ USA |